These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3145248)

  • 1. The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).
    Callard RE; Lau YL; Shields JG; Smith SH; Cairns J; Flores-Romo L; Gordon J
    Immunology; 1988 Nov; 65(3):379-84. PubMed ID: 3145248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
    Lau YL; Shields JG; Levinsky RJ; Callard RE
    Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines.
    Bonnefoy JY; Defrance T; Peronne C; Menetrier C; Rousset F; Pène J; De Vries JE; Banchereau J
    Eur J Immunol; 1988 Jan; 18(1):117-22. PubMed ID: 2831064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII).
    Warrington RJ; Rutherford WJ; Wong SK; Cook JM; Rector ES
    J Immunol; 1989 Oct; 143(8):2546-52. PubMed ID: 2529311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of LFA-1-deficient B cells to interleukin 4 (BSF-1) and low molecular weight B cell growth factor (BCGFlow).
    Shields JG; Smith SH; Strobel S; Levinsky RJ; Defrance T; De Vries J; Banchereau J; Callard RE
    Eur J Immunol; 1988 Feb; 18(2):255-9. PubMed ID: 2832180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
    Tosato G; Gerrard TL; Goldman NG; Pike SE
    J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays.
    Clutterbuck E; Shields JG; Gordon J; Smith SH; Boyd A; Callard RE; Campbell HD; Young IG; Sanderson CJ
    Eur J Immunol; 1987 Dec; 17(12):1743-50. PubMed ID: 3500861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human B lymphoblastoid cell lines provide an interleukin 1-like signal for mitogen-treated T lymphocytes via direct cell contact.
    Arnold A; Lipkowitz S; Suthanthiran M; Novogrodsky A; Stenzel KH
    J Immunol; 1985 Jun; 134(6):3876-81. PubMed ID: 2985701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
    Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
    J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the phenotype and immunoglobulin secretion of human B cells following co-culture with cells of an EBV+ lymphoblastoid line or fusion with mouse plasmacytoma cells. Studies in short-term and long-term culture.
    Ling NR; Lowe JA
    Clin Exp Immunol; 1989 Feb; 75(2):311-6. PubMed ID: 2539279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line.
    Yoshizaki K; Nakagawa T; Fukunaga K; Tseng LT; Yamamura Y; Kishimoto T
    J Immunol; 1984 Jun; 132(6):2948-54. PubMed ID: 6202767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines.
    Wakasugi H; Dokhelar MC; Garson D; Harel-Bellan A; Fradelizi D; Tursz T
    Eur J Immunol; 1985 Mar; 15(3):256-61. PubMed ID: 3872216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).
    Shimizu K; Hirano T; Ishibashi K; Nakano N; Taga T; Sugamura K; Yamamura Y; Kishimoto T
    J Immunol; 1985 Mar; 134(3):1728-33. PubMed ID: 2981920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
    Torsteinsdottir S; Masucci MG; Szigeti R; Bishara A; Brautbar C; Klein G; Klein E
    Mol Biol Med; 1984 Aug; 2(4):285-99. PubMed ID: 6443579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of CD44-hyaluronan interactions in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid B cells by PMA and interleukin-4.
    Kryworuchko M; Gee K; Diaz-Mitoma F; Kumar A
    Cell Immunol; 1999 May; 194(1):54-66. PubMed ID: 10357881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human B cell proliferation in response to IL-4 is associated with enhanced production of B cell-derived growth factors.
    Tadmori W; Lee HK; Clark SC; Choi YS
    J Immunol; 1989 Feb; 142(3):826-32. PubMed ID: 2783602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel human B cell activation antigen involved in B cell growth factor-dependent proliferation.
    Tseng CT; Springgate CF; Tadmori W; Choi YS
    J Immunol; 1988 Apr; 140(7):2305-11. PubMed ID: 2450917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
    Kawano M; Iwato K; Kuramoto A
    J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
    Klein G; Ehlin-Henriksson B; Schlossman SF
    J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.